NEOGENOMICS INC — Director's Dealing 2017

May 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-04-28

Reporting Person: BALLIET JENNIFER (VP and Chief Culture Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-28	Stock Option (Right to Buy)	$7.52	A	60000	Acquired	2022-04-28	Common Stock (60000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13383	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$3.76	2018-04-16	Common Stock (7500)	7500	Direct
Stock Option (Right to Buy)	$3.45	2019-03-05	Common Stock (15000)	15000	Direct
Stock Option (Right to Buy)	$4.78	2020-05-04	Common Stock (120000)	120000	Direct
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (50000)	50000	Direct

Footnotes

F1: On April 16, 2013, Jennifer Balliet was granted 7,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F2: On March 5, 2014, Jennifer Balliet was granted 15,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F3: On May 4, 2015, Jennifer Balliet was granted 120,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F4: On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F5: On April 28, 2017, Jennifer Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversaries of the grant date.